PLUS Stock Analysis: ePlus | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 2.151m USD | 12M Return: 27.1% | US2942681071 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.5M
EPS Trend: 8.7%
Qual. Beats: 1
Rev. Trend: 52.5%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ePlus inc. (NASDAQ: PLUS) is a U.S.-headquartered provider of information technology (IT) solutions, operating across three segments: Product Services, Professional Services, and Managed Services. Its offerings span third-party hardware and software resale, IT supply chain management, consulting, cloud and security advisory, staff augmentation, and lifecycle support services. The company serves a diverse customer base including telecommunications, media, technology, government, education, healthcare, and financial services clients. Founded in 1990 and headquartered in Herndon, Virginia, ePlus was formerly known as MLC Holdings, Inc. before adopting its current name in 1999.
As a member of the GICS Technology Distributors sub-industry, ePlus operates within a sector where resellers purchase hardware and software from original equipment manufacturers (OEMs) and other vendors, then resell those products to end customers alongside value-added services such as configuration, integration, and managed support. This hybrid distribution-and-services model allows technology distributors to earn both product margins and recurring service revenue, often generating stronger customer stickiness through multi-year support and managed services contracts.
- Managed Services revenue accelerates on cloud and security demand
- Product Services margins face hardware pricing pressure
- Enterprise IT capex weakens amid macro uncertainty
| Net Income: 125.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.66 > 1.0 |
| NWC/Revenue: 32.45% < 20% (prev 33.39%; Δ -0.94% < -1%) |
| CFO/TA 0.03 > 3% & CFO 59.2m > Net Income 125.8m |
| Net Debt (-424.7m) to EBITDA (198.7m): -2.14 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.1m) vs 12m ago -1.21% < -2% |
| Gross Margin: 24.71% > 18% (prev 25.85%; Δ -1.14% > 0.5%) |
| Asset Turnover: 133.9% > 50% (prev 118.9%; Δ 14.96% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.43 (Total Current Assets 1.50b - Total Current Liabilities 704.3m) / Total Assets 1.87b |
| B: 0.52 (Retained Earnings 979.2m / Total Assets 1.87b) |
| C: 0.09 (EBIT TTM 172.3m / Avg Total Assets 1.83b) |
| D: 1.35 (Book Value of Equity 1.07b / Total Liabilities 795.0m) |
| Altman-Z'' = 6.56 = AAA |
| DSRI: 0.92 (Receivables 783.3m/739.5m, Revenue 2.45b/2.14b) |
| GMI: 1.05 (GM 25.85% / 24.71%) |
| AQI: 0.89 (AQ_t 0.14 / AQ_t-1 0.16) |
| SGI: 1.15 (Revenue 2.45b / 2.14b) |
| TATA: 0.04 (NI 125.8m - CFO 59.2m) / TA 1.87b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of November 07, 2026, the stock is trading at USD 92.11 with a total of 443,893 shares traded. Over the past week, the price has changed by -0.86%, over one month by -2.18%, over three months by +2.27% and over the past year by +27.10%.
Current recommended Stop Loss: 85.20 (which is 7.5% or 1.8 ATR below the current price).
ePlus has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy PLUS.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 111 | 20.5% |
P/E Trailing = 17.6888
P/E Forward = 16.9205
P/S = 0.8782
P/B = 2.2018
P/EG = 1.0569
Revenue TTM = 2.45b USD
EBIT TTM = 172.3m USD
EBITDA TTM = 198.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 112.5m USD (from shortLongTermDebt, last quarter)
Debt = 24.1m USD (from shortLongTermDebtTotal, last fiscal year) + Leases 7.95m
Net Debt = -424.7m USD (calculated: Debt 24.1m - CCE 448.9m)
Enterprise Value = 1.73b USD (2.15b + Debt 24.1m - CCE 448.9m)
Interest Coverage Ratio = unknown (Ebit TTM 172.3m / Interest Expense TTM 0.0)
EV/FCF = 31.51x (Enterprise Value 1.73b / FCF TTM 54.8m)
FCF Yield = 3.17% (FCF TTM 54.8m / Enterprise Value 1.73b)
FCF Margin = 2.23% (FCF TTM 54.8m / Revenue TTM 2.45b)
Net Margin = 5.12% (Net Income TTM 125.8m / Revenue TTM 2.45b)
Gross Margin = 24.71% ((Revenue TTM 2.45b - Cost of Revenue TTM 1.85b) / Revenue TTM)
Gross Margin QoQ = 23.31% (prev 24.23%)
Tobins Q-Ratio = 0.92 (Enterprise Value 1.73b / Total Assets 1.87b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 24.1m)
Taxrate = 28.73% (51.3m / 178.6m)
NOPAT = 122.8m (EBIT 172.3m * (1 - 28.73%))
Current Ratio = 2.13 (Total Current Assets 1.50b / Total Current Liabilities 704.3m)
Debt / Equity = 0.02 (Debt 24.1m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = -2.14 (Net Debt -424.7m / EBITDA 198.7m)
Debt / FCF = -7.75 (Net Debt -424.7m / FCF TTM 54.8m)
Total Stockholder Equity = 1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.86% (Net Income 125.8m / Total Assets 1.87b)
RoE = 11.84% (Net Income TTM 125.8m / Total Stockholder Equity 1.06b)
RoCE = 14.82% (EBIT 172.3m / Capital Employed (Total Assets 1.87b - Current Liab 704.3m))
RoIC = 11.75% (NOPAT 122.8m / Invested Capital 1.05b)
WACC = 7.51% (E(2.15b)/V(2.17b) * Re(7.59%) + D(24.1m)/V(2.17b) * Rd(0.0%) * (1-Tc(0.29)))
Discount Rate = 7.59% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.78 | Cagr: -1.24%
[DCF] Terminal Value 73.10% ; FCFF base≈73.1m ; Y1≈64.1m ; Y5≈51.8m
[DCF] Fair Price = 48.14 (EV 831.3m - Net Debt -424.7m = Equity 1.26b / Shares 26.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 8.70 | EPS CAGR: 0.52% | SUE: 1.54 | # QB: 1
Revenue Correlation: 52.52 | Revenue CAGR: 3.59% | SUE: 0.13 | # QB: 0
EPS current Quarter (2026-12-31): EPS=1.53 | Chg30d=+0.00% | Revisions=+0% | Analysts=2
EPS current Year (2027-03-31): EPS=5.47 | Chg30d=+0.00% | Revisions=+40% | GrowthEPS=+1.6% | GrowthRev=+4.7%
EPS next Year (2028-03-31): EPS=5.96 | Chg30d=+0.00% | Revisions=+40% | GrowthEPS=+8.8% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +44% (up=5, down=1)